Gonadotropin-releasing hormone agonists combined with hormone replacement therapy improves the live birth rate of patients with thin endometrium and cured chronic endometritis.

BACKGROUND: Both thin endometrium and chronic endometritis (CE) have adverse effects on pregnancy outcomes. Recently, it is often believed that downregulating gonadotropin-releasing hormone agonists (GnRH-a) might enhance endometrial receptivity and…

Preview only. Read the full abstract at the source